Monica Terlizzo
Overview
Explore the profile of Monica Terlizzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moore J, Green M, Santaolalla A, Deere H, Evans R, Elshafie M, et al.
J Clin Oncol
. 2023 Jul;
41(28):4522-4534.
PMID: 37499209
Purpose: There is limited evidence regarding the prognostic effects of pathologic lymph node (LN) regression after neoadjuvant chemotherapy for esophageal adenocarcinoma, and a definition of LN response is lacking. This...
2.
Hussain K, Kanji A, Zaheri S, Malek D, Terlizzo M, Weir J, et al.
Clin Exp Dermatol
. 2023 Feb;
48(3):254-256.
PMID: 36763756
No abstract available.
3.
Doyle J, Bhogal R, Terlizzo M, Mavroeidis V
Ir J Med Sci
. 2022 Oct;
192(4):1801-1805.
PMID: 36251107
Appendiceal tumours encompass a wide spectrum of differential diagnoses and frequently present with clinical features of appendicitis. We report the case of a 43-year-old woman who presented with epigastric pain,...
4.
Pericleous S, Doran S, Wotherspoon A, Terlizzo M, Riddell A, Brown G, et al.
World J Nucl Med
. 2022 Jul;
21(2):112-119.
PMID: 35865160
Gallbladder cancer has a poor prognosis and imaging can have variable diagnostic accuracy. We assessed the ability of preoperative F-fluorodeoxyglucose positron emission tomography computed tomography ( F-FDG-PET/CT) imaging to predict...
5.
Chong I, Starling N, Rust A, Alexander J, Aronson L, Llorca-Cardenosa M, et al.
J Clin Med
. 2021 Jan;
10(2).
PMID: 33435284
Background: The application of massively parallel sequencing has led to the identification of aberrant druggable pathways and somatic mutations within therapeutically relevant genes in gastro-oesophageal cancer. Given the widespread use...
6.
Chawla S, Turner N, Terlizzo M, Heelan K
Australas J Dermatol
. 2020 Nov;
62(2):210-212.
PMID: 33216943
Pertuzumab and trastuzumab are monoclonal antibody inhibitors targeting human epidermal growth factor receptor 2 (HER-2) and are increasingly being utilised in the management of HER2-positive breast cancer, having been demonstrated...
7.
Lord A, Moran B, Abulafi M, Rasheed S, Nagtegaal I, Terlizzo M, et al.
BMJ Open
. 2020 Oct;
10(10):e033395.
PMID: 33033006
Introduction: Tumour deposits (TDs) are a poor prognostic marker when seen on pathology, and are worse than lymph node metastases (LNMs). They are now being reported on MRI as discontinuous...
8.
DSouza N, Lord A, Shaw A, Patel A, Balyasnikova S, Tudyka V, et al.
Eur J Surg Oncol
. 2020 Feb;
46(9):1668-1672.
PMID: 32061459
Background: A pre-operative imaging landmark to define the rectum would optimise clinical care of rectal cancer patients and research efforts to improve outcomes. The sigmoid take-off has been suggested as...
9.
Khakoo S, Carter P, Brown G, Valeri N, Picchia S, Antonietta Bali M, et al.
Clin Cancer Res
. 2019 Dec;
26(1):183-192.
PMID: 31852830
Purpose: Response to preoperative chemo-radiotherapy (CRT) varies. We assessed whether circulating tumor DNA (ctDNA) might be an early indicator of tumor response or progression to guide therapy adaptation in rectal...
10.
Davidson M, Aronson L, Howard-Reeves J, Bryant H, Cutts R, Hulkki-Wilson S, et al.
Eur J Cancer
. 2019 Oct;
122:12-21.
PMID: 31606655
Introduction: The MYC proto-oncogene is among the most commonly dysregulated genes in human cancers. We report screening data from the iMYC trial, an ongoing phase II study assessing ibrutinib monotherapy...